IL2 and COVID-19: COVID-19 respiratory distress begins with an early inflammation so that pulmonary compliance is reduced by activation of intercellular inflammatory pathways, cytokine synthesis, or storm (excessive release of IL-2, IL-6, IL-7, IL-8, IL10, and TNF-α).